What Should Investors Know About Alexandria Real Estate Equities (ARE) Stock?

Shares of Real Estate sector company Alexandria Real Estate Equities moved 8.0% today, and are now trading at a price of $118.14. The large-cap stock's daily volume was 3,033,254 compared to its average volume of 1,232,987. The S&P 500 index returned a 1.0% performance.

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. The company is based in Pasadena and has 593 full time employees. Its market capitalization is $20,529,778,688. Alexandria Real Estate Equities currently offers its equity investors a dividend that yields 4.5% per year.

12 analysts are following Alexandria Real Estate Equities and have set target prices ranging from $108.0 to $186.0 per share. On average, they have given the company a rating of buy. At today's prices, ARE is trading -11.12% away from its average analyst target price of $132.92 per share.

Over the last year, ARE shares have gone down by -22.0%, which represents a difference of -36.0% when compared to the S&P 500. The stock's 52 week high is $172.65 per share and its 52 week low is $90.73. Alexandria Real Estate Equities has averaged free cash flows of $-1089002833.3 over the last 6 years, with a mean growth rate of -33.1%. It is likely that the stock will keep following its current negative performance trend while the underlying business is experiencing such poor cash flows.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 1,603,096 3,584,295 -1,981,199 1.58
2022 1,294,321 3,307,313 -2,012,992 -86.45
2021 1,010,197 2,089,849 -1,079,652 -91.88
2020 882,510 1,445,171 -562,661 -4.06
2019 683,857 1,224,541 -540,684 -51.52
2018 570,339 927,168 -356,829
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.